Venture Life Group Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jerry Randall

Algemeen directeur

UK£496.0k

Totale compensatie

Percentage CEO-salaris	49.8%
Dienstverband CEO	14.8yrs
Eigendom CEO	1.7%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	4.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Jerry Randall's beloning veranderd ten opzichte van Venture Life Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	UK£742k
Mar 31 2024	n/a	n/a	UK£832k
Dec 31 2023	UK£496k	UK£247k	UK£921k
Sep 30 2023	n/a	n/a	UK£83k
Jun 30 2023	n/a	n/a	-UK£756k
Mar 31 2023	n/a	n/a	-UK£118k
Dec 31 2022	UK£344k	UK£235k	UK£520k
Sep 30 2022	n/a	n/a	UK£2m
Jun 30 2022	n/a	n/a	UK£3m
Mar 31 2022	n/a	n/a	UK£3m
Dec 31 2021	UK£445k	UK£280k	UK£2m
Sep 30 2021	n/a	n/a	UK£1m
Jun 30 2021	n/a	n/a	UK£347k
Mar 31 2021	n/a	n/a	UK£1m
Dec 31 2020	UK£327k	UK£279k	UK£2m
Sep 30 2020	n/a	n/a	UK£3m
Jun 30 2020	n/a	n/a	UK£3m
Mar 31 2020	n/a	n/a	UK£2m
Dec 31 2019	UK£342k	UK£271k	UK£904k
Sep 30 2019	n/a	n/a	UK£632k
Jun 30 2019	n/a	n/a	UK£360k
Mar 31 2019	n/a	n/a	UK£298k
Dec 31 2018	UK£313k	UK£211k	UK£236k
Sep 30 2018	n/a	n/a	-UK£7k
Jun 30 2018	n/a	n/a	-UK£250k
Mar 31 2018	n/a	n/a	-UK£308k
Dec 31 2017	UK£302k	UK£195k	-UK£367k

Compensatie versus markt: De totale vergoeding ($USD 628.86K ) Jerry } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 476.59K ).

Compensatie versus inkomsten: De vergoeding van Jerry is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Jerry Randall (60 yo)

14.8yrs

Tenure

UK£495,994

Compensatie

Mr. Jeremy Anthony Philip Randall, also known as Jerry, ACA serves as Member of Commercial Advisory Board at ValiRx plc. He is the Co-founder since 2010 and serves as its Chief Executive Officer of Venture...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jeremy Anthony Randall	Co-Founder	14.7yrs	UK£495.99k	1.73% € 1.0m
Daniel Wells	CFO & Director	2.9yrs	UK£344.02k	geen gegevens
Lodovico Braguti	Chief Manufacturing Officer & Executive Director	10.7yrs	UK£424.66k	3.03% € 1.8m
Paul McGreevy	Independent Non-Executive Chair	2.5yrs	UK£70.43k	0.63% € 367.7k
Mark Adams	Senior Independent Director	2.1yrs	UK£38.25k	0.14% € 79.8k
Stefano Manfredini	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Vincenzo Politi	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
John Griffin	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Carl Dempsey	Independent Non-Executive Director	6.2yrs	UK£35.67k	0.12% € 67.7k

4.5yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 17V wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).

Venture Life Group Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Independent Non-Executive Chair recently bought €60k worth of stock

Co-Founder recently sold €57k worth of stock

Venture Life Group plc, Annual General Meeting, Jun 04, 2024

Sharon Daly (nee Collins) to Leave as Director of Venture Life Group plc, Effective 3 August 2023

No independent directors

No independent directors

Recent updates

Independent Non-Executive Chair recently bought €60k worth of stock

Venture Life Group plc (AIM:VLG) acquired Health and Her Ltd. from Wales Angel Co-investment Fund and Development Bank of Wales Plc for £10 million.

First half 2024 earnings released: UK£0.013 loss per share (vs UK£0.012 loss in 1H 2023)

Co-Founder recently sold €57k worth of stock

Venture Life Group plc Provides Revenue Guidance for the Full Year 2024

Venture Life Group plc to Report First Half, 2024 Results on Sep 30, 2024

Venture Life Group plc, Annual General Meeting, Jun 04, 2024

New minor risk - Financial data availability

Venture Life Group plc to Report Fiscal Year 2023 Results on Apr 09, 2024

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.002 loss in 1H 2022)

Sharon Daly (nee Collins) to Leave as Director of Venture Life Group plc, Effective 3 August 2023

Full year 2022 earnings released

No independent directors

Venture Life Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Venture Life Group plc (AIM:VLG) acquired Hl Healthcare Limited for GBP 13 million.

No independent directors

Venture Life Announces Directorate Changes

First half 2022 earnings released: UK£0.002 loss per share (vs UK£0.004 loss in 1H 2021)

Venture Life Group plc Provides Earnings Guidance for the Six Months Ended 30 June 2022

Non-Executive Chair recently bought €57k worth of stock

Venture Life Group plc, Annual General Meeting, Jun 20, 2022

Non-Executive Chair recently bought €59k worth of stock

Venture Life Group plc Announces Directorate Changes

Full year 2021 earnings released: EPS: UK£0.019 (vs UK£0.027 in FY 2020)

Venture Life Group Appoints Paul McGreevy as Non-Executive Chair

No independent directors

Venture Life Group plc Reiterates Earnings Guidance for the Fiscal Year 2021

Venture Life Announces UK-Led Clinical Trial Suggests Certain Types of Mouthwash Can Inactivate SARS-CoV-2 in Mouth for Up to 1 Hour

Venture Life Group plc to Report Fiscal Year 2021 Results on Mar 24, 2022

First half 2021 earnings released: UK£0.004 loss per share (vs UK£0.019 profit in 1H 2020)

Venture Life Group plc (AIM:VLG) acquired Series of Oncology Support Product Assets of Helsinn Healthcare for CHF 6 million.

Venture Life Group plc (AIM:VLG) acquired BBI Healthcare Limited from BBI Diagnostics Group Limited for £36 million.

Full year 2020 earnings released: EPS UK£0.027 (vs UK£0.011 in FY 2019)

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd